stars 1 stars 2 stars 3

1ST Biotherapeutics is a science-driven biopharmaceutical company focused on the development of breakthrough therapies in neurodegenerative diseases, immuno-oncology, and rare diseases. Founded in 2016, 1ST Biotherapeutics has rapidly developed a deep pipeline of first-in-class investigational therapeutics with clear mechanism for proper disease modification and with good pharmacological properties. 1ST Biotherapeutics is based in Seongnam, South Korea.

1ST Bio Questions

The 1ST Bio annual revenue was $4 million in 2026.

2 people are employed at 1ST Bio.

1ST Bio is based in Seongnam, Kyonggi-do.

The NAICS codes for 1ST Bio are [541, 54, 541714, 5417, 54171].

The SIC codes for 1ST Bio are [873, 87].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users